Basilea Pharmaceutica Profile

68.33
USD 0.005  0.0073%
2147483647%

Basilea Pharmaceutica AG Risk Profiles

Key Fundamentals

Basilea Pharmaceutica Against Markets

Basilea Pharmaceutica AG, together with its subsidiaries, operates as an integrated biopharmaceutical company. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. Basilea Pharmaceutica operates under Biotechnology classification in USA and traded on OTC Market. It employs 228 people. more
NameBasilea Pharmaceutica AG
CEORonald ScottView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGrenzacherstrasse 487
ExchangeOTC Market
SectorHealthcare
BenchmarkDOW
Websitewww.basilea.com
Phone41 61 606 11 11
CurrencyUSD - US Dollar

Directors

Basilea Pharmaceutica Corporate Directors
Thomas Rinderknecht Member of the Board of Directors
Daniel Lew Member of the Board of Directors
Domenico Scala Member of the Board of Directors
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.